Studies on antitumor activity of bacterial lipopolysaccharide.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004926:Escherichia coli / Q000032:analysis; D006367:HeLa Cells / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects; D008070:Lipopolysaccharides / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D012157:Mononuclear Phagocyte System / Q000187:drug effects; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000032:analysis; D011749:Pyrogens; D011817:Rabbits; D012510:Sarcoma 180 / Q000188:drug therapy; D013210:Staphylococcus / Q000032:analysis; D013291:Streptococcus / Q000032:analysis
D000970:Antineoplastic Agents; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D011749:Pyrogens